Learn more

SHOLEKS DEV GMBKH

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    238,856
About

SHOLEKS DEV GMBKH has a total of 12 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Russian Federation. Its main competitors in its focus markets pharmaceuticals are BAICHWAL ANAND R, VENKATESH GOPI M and PHARMA TWO B LTD.

Patent filings in countries

World map showing SHOLEKS DEV GMBKHs patent filings in countries
# Country Total Patents
#1 Russian Federation 12

Patent filings per year

Chart showing SHOLEKS DEV GMBKHs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

Top inventors

# Name Total Patents
#1 Uvarov Nikolaj Aleksandrovich 12
#2 Mikhajlov Oleg Rostislavovich 12
#3 Malin Aleksandr Aleksandrovich 11

Latest patents

Publication Filing date Title
RU2577289C1 Aerosol preparation based on fenoterol hydrobromide for treating respiratory diseases
RU2536253C1 Combined aerosol preparation for treating respiratory diseases
RU2521975C1 Aerosol combination of salmeterol and fluticasone for treating respiratory diseases
RU2519653C1 Aerosol preparation of ipratropium bromide for treating respiratory diseases
RU2504402C1 Inhalation formulation in form of aerosol for treating bronchial asthma and chronic obstructive pulmonary disease
RU2493827C1 Stable combined solution of fenoterol hydrobromide and ipratropium bromide
RU2496477C1 Ipratropium bromide solution
RU2510267C2 Inhalation preparation for treating bronchial asthma and chronic obstructive pulmonary disease and method for preparing it
RU2504382C1 Inhalation preparation for treating bronchail asthma and chronic obstructive pulmonary disease and method for preparing it
RU2522213C2 Pharmaceutical inhaled medication for treatment of bronchial asthma and chronic obstructive lung disease, containing micronised tiotropium bromide as active substance and method of its production
RU2479304C1 Stable solution of fenoterol hydrobromide
RU2494730C1 Inhalation preparation for treating respiratory diseases containing micronised salmeterol xinafoate and micronised fluticasone propionate as active substances and method for preparing it